A Review of the Potential Mechanisms of Action of Baclofen in Alcohol Use Disorder

被引:31
|
作者
de Beaurepaire, Renaud [1 ]
机构
[1] Grp Hosp Paul Guiraud, Villejuif, France
来源
FRONTIERS IN PSYCHIATRY | 2018年 / 9卷
关键词
GABA receptor b; reward network; amygdala; Pavlovian associations; substitution; (morphine; methadone; buprenorphin); HIGH-DOSE BACLOFEN; VENTRAL TEGMENTAL AREA; GABA-B RECEPTOR; POSITIVE ALLOSTERIC MODULATOR; MESOLIMBIC DOPAMINE SYSTEM; TERM ABSTINENT ALCOHOLICS; RESTING-STATE SYNCHRONY; CENTRAL-NERVOUS-SYSTEM; PREFERRING SP RATS; BINGE-LIKE ETHANOL;
D O I
10.3389/fpsyt.2018.00506
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Baclofen, a GABA-B receptor agonist, is a promising treatment for alcohol use disorder (AUD). Its mechanism of action in this condition is unknown. GABA-B receptors interact with many biological systems potentially involved in AUD, including transduction pathways and neurotransmitter systems. Preclinical studies have shown that GABA-B receptors are involved in memory storage and retrieval, reward, motivation, mood and anxiety; neuroimaging studies in humans show that baclofen produces region-specific alterations in cerebral activity; GABA-B receptor activation may have neuroprotective effects; baclofen also has anti-inflammatory properties that may be of interest in the context of addiction. However, none of these biological effects fully explain the mechanism of action of baclofen in AUD. Data from clinical studies have provided a certain number of elements which may be useful for the comprehension of its mechanism of action: baclofen typically induces a state of indifference toward alcohol; the effective dose of baclofen in AUD is extremely variable from one patient to another; higher treatment doses correlate with the severity of the addiction; many of the side effects of baclofen resemble those of alcohol, raising the possibility that baclofen acts as a substitution drug; usually, however, there is no tolerance to the effects of baclofen during long-term AUD treatment. In the present article, the biological effects of baclofen are reviewed in the light of its clinical effects in AUD, assuming that, in many instances, clinical effects can be reliable indicators of underlying biological processes. In conclusion, it is proposed that baclofen may suppress the Pavlovian association between cues and rewards through an action in a critical part of the dopaminergic network (the amygdala), thereby normalizing the functional connectivity in the reward network. It is also proposed that this action of baclofen is made possible by the fact that baclofen and alcohol act on similar brain systems in certain regions of the brain.
引用
收藏
页数:12
相关论文
共 50 条
  • [22] Bipolar Disorder and Alcohol Use Disorder: A Review
    Farren, Conor K.
    Hill, Kevin P.
    Weiss, Roger D.
    CURRENT PSYCHIATRY REPORTS, 2012, 14 (06) : 659 - 666
  • [23] Bipolar Disorder and Alcohol Use Disorder: A Review
    Conor K. Farren
    Kevin P. Hill
    Roger D. Weiss
    Current Psychiatry Reports, 2012, 14 : 659 - 666
  • [24] Diet and Bipolar Disorder: A Review of Its Relationship and Potential Therapeutic Mechanisms of Action
    Lopresti, Adrian L.
    Jacka, Felice N.
    JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE, 2015, 21 (12) : 733 - 739
  • [25] Instrumental and Pavlovian Mechanisms in Alcohol Use Disorder
    Nuria Doñamayor
    Claudia Ebrahimi
    Maria Garbusow
    Friederike Wedemeyer
    Florian Schlagenhauf
    Andreas Heinz
    Current Addiction Reports, 2021, 8 : 156 - 180
  • [26] Instrumental and Pavlovian Mechanisms in Alcohol Use Disorder
    Donamayor, Nuria
    Ebrahimi, Claudia
    Garbusow, Maria
    Wedemeyer, Friederike
    Schlagenhauf, Florian
    Heinz, Andreas
    CURRENT ADDICTION REPORTS, 2021, 8 (01) : 156 - 180
  • [27] High-dose baclofen for alcohol use disorder 20 years after
    Granger, Bernard
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2025, 209 (01): : 114 - 122
  • [28] Baclofen in the Treatment of Patients With Alcohol Use Disorder and Other Mental Health Disorders
    Agabio, Roberta
    Leggio, Lorenzo
    FRONTIERS IN PSYCHIATRY, 2018, 9
  • [29] Acamprosate better than baclofen for alcohol use disorder in cirrhosis: fact or myth?
    Giri, Suprabhat
    Sundaram, Sridhar
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2022, 34 (06) : 724 - 724
  • [30] Alcohol Use Disorder and Dementia: A Review
    Zahr, Natalie M.
    ALCOHOL RESEARCH-CURRENT REVIEWS, 2024, 44 (01):